Common Contracts
1 similar Clinical Study Agreement contracts
CLINICAL STUDY AGREEMENT PROTOCOL: OP0595-5 SITE: ME5-11-03 MEIJISEIKA PHARMA CO., LTD. VERSION: VERSION#1 COUNTRY: SLOVAKIA ZMLUVA O KLINICKOM SKÚŠANÍ PROTOKOL: OP0595-5 PRACOVISKO: ME5-11-03 MEIJISEIKA PHARMA CO., LTD. VERZIA:VERZIAČ. 1 KRAJINA:...Clinical Study Agreement • August 29th, 2023
CLINICAL STUDY AGREEMENTThis clinical study agreement (“Agreement”), effective from the date of publication in the Central Register of Contracts (the “Effective Date”), is entered into by and among Medpace Clinical Research, LLC, with its principal office and place of business at 5375 Medpace Way, Cincinnati, Ohio 45227 ("Medpace”), and Univerzitna nemocnica Martin a clinical research site with its principal office and place of business at Kollarova 2, 036 59 Martin, Slovakia("Institution”) andhaving an addressat ("PrincipalInvestigator”). Medpace, Institution and Principal Investigator are sometimes collectively referred to herein as parties (the “Parties”). WHEREAS, Meiji Seika Pharma Co., Ltd. (“Sponsor”) is sponsoring a clinical study on the compound Nacubactam (the “Study Drug”), in accordance with Protocol No. OP0595-5, titled A Phase 3, Multi-Center, Randomized, Double- Blind Study to Evaluate the Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imi
